Results 61 to 70 of about 142,321 (206)

Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma

open access: yes, 2012
Background: Hodkin s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure.
Renné Christoph   +5 more
core   +1 more source

Malignant lymphomas (ML) and HIV/AIDS Infection in Tanzania. [PDF]

open access: yes, 2008
\ud HIV infection is reported to be associated with some malignant lymphomas (ML) so called AIDS-related lymphomas (ARL), with an aggressive behavior and poor prognosis.
Mwakigonja Amos R   +5 more
core   +1 more source

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project

open access: yes, 2009
BACKGROUND: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and therapeutic results for adult T-cell
Ullrich F   +64 more
core   +1 more source

Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis

open access: yes, 2017
Background: Primary cutaneous T-cell lymphomas (CTCL) are heterogenous extranodal non-Hodgkin lymphomas including a few distinct and provisional entities.
Win, Khin Than;Liau, Jau-Yu;Chen, Bo-Jung;Takata, Katsuyoshi;Chen, Chiao-Yun;Li, Chi-Cheng;Hsiao, Cheng-Hsiang;Chuang, Shih-Sung   +1 more
core   +1 more source

ESMO Consensus conferences:guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma [PDF]

open access: yes, 2013
To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour.
Zinzani P   +49 more
core   +1 more source

The function and origin of the CD4+ T cell in the classical Hodgkin lymphoma microenvironment

open access: yes, 2012
PhDClassical Hodgkin lymphoma (CHL) is a germinal centre B cell malignancy where the bulk of the tumour comprises a non-clonal immune infiltrate enriched for CD4+ T cells.
Greaves, Paul
core  

Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma

open access: yes, 2011
Background: The prognosis of T-cell lymphoma is poor. To explore the addition of the monoclonal antibody alemtuzumab, we studied the efficacy and tolerability of an intensified alemtuzumab-chemotherapy combination for aggressive T-cell lymphoma in a ...
Luten, M.   +13 more
core   +1 more source

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

open access: yes, 2003
In the present study the clinicopathologic and immunophenotypic features of 82 patients with a CD30(-) peripheral T-cell lymphoma, unspecified, presenting in the skin were evaluated.
Meijer, CJLM   +8 more
core   +1 more source

An update on the management of peripheral T-cell lymphoma and emerging treatment options

open access: yes, 2011
Adrienne A Phillips1, Colette Owens2, Sangmin Lee1, Govind Bhagat31Division of Medical Oncology, Department of Medicine, 2Division of General Medicine, Department of Medicine, 3Department of Pathology and Cell Biology, Columbia University Medical Center ...
Lee S, Bhagat G, Owens C, Phillips AA
core  

Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.

open access: yes, 2016
Nodal follicular helper T-cell-derived lymphoproliferations (specifically the less common peripheral T-cell lymphomas of follicular type) exhibit a spectrum of histologic features that may mimic reactive hyperplasia or Hodgkin lymphoma.
Gurbuxani, Sandeep   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy